以下资料只供本校师生阅读，不得下载！

Interstitial lung disease

• Surgical biopsy-its appropriateness in diagnosing interstitial lung disease
• Quality of life and health status in interstitial lung diseases.
• Pulmonary involvement in ankylosing spondylitis.
• Mycobacterial antigens may be important in sarcoidosis pathogenesis.
• Is HRCT the best way to diagnose idiopathic interstitial fibrosis
• Interstitial lung disease in rheumatoid arthritis
• Induced sputum in interstitial lung diseases.
• Idiopathic pulmonary fibrosis
• Idiopathic pulmonary fibrosis.
• De-escalation in lower respiratory tract infections.
• Airway involvement in interstitial lung disease.

  back

Corneal and external disorders

• Update on ocular graft versus host disease.
• Preserving the cornea
• Genetics of corneal dystrophies
• Diagnosis and management of Acanthamoeba keratitis.
• Deep anterior lamellar keratoplasty.
• Crosslinking treatment of progressive keratoconus
• Corneal structure and biomechanics

  back

Systemic lupus erythematosus and Sjogren syndrome

• Systemic lupus erythematosus and Sjogren syndrome
• Sex and systemic lupus erythematosus
• Pathogenesis and treatment of systemic lupus erythematosus nephritis
• Epstein-Barr virus and systemic lupus erythematosus
• Clinical trial design in systemic lupus erythematosus
• B cell receptor signaling in human systemic lupus erythematosus

  back

Hemostasis and thrombosis

• Who should be tested for thrombophilia
• Thrombosis as a harbinger of cancer
• The endothelial protein C receptor
• Risk of inhibitors in haemophilia and the type of factor replacement
• Retrievable vena cava filters
• Prophylaxis and treatment of thrombophilia in pregnancy
• Genetic influences on the response to warfarin
• Gene therapy for hemophilia
• Diagnosis of pulmonary embolism
• Continuous infusion of coagulation factors
• Aspirin resistance
• Antiphospholipid antibodies and the antiphospholipid syndrome
• A critical comparison of platelet preparation methods

  back

Inflammatory bowel diseases

• Management of inflammatory bowel diseases in Eastern Europe
• Inflammatory bowel disease
• Serologic Markers in Inflammatory Bowel Disease
• New genes in inflammatory bowel disease
• Evolving knowledge and therapy of inflammatory bowel disease
• Biologic Therapy for Inflammatory Bowel Disease
• clinical update
• Medical treatment of inflammatory bowel diseases
• The Vasculature and Inflammatory Bowel Disease-Contribution to Pathogenesis and Clinical Pathology
• Imaging inflammatory bowel disease using bowel ultrasound

  back

Amebiasis

• Archives of Medical Research and the Seminars on Amebiasis
• Pathogenesis of Acute Experimental Liver Amebiasis
• Calcium-Binding Proteins of Entamoeba histolytica
• Epigenetic Silencing of Gene Expression in Entamoeba histolytica
• The Cytoskeleton of Entamoeba histolytica
• The Current Status of an Amebiasis Vaccine
• Recent Progress in Vaccines for Amebiasis
• Prevalence and Incidence of Entamoeba histolytica Infection in South Africa and Egypt
• New Insights into Molecular Mechanisms of Phagocytosis in Entamoeba histolytica by Proteomic Analysis
• Methods for the Investigation of Diversity in Entamoeba histolytica
• Host Tissue Invasion by Entamoeba histolytica Is Powered by Motility and Phagocytosis
• Experimental Amebiasis
• Epidemiology of Amebiasis in Mexico
• Epidemiology and Treatment of Amebiasis in Hué, Vietnam
• Diversity of Clinical Isolates of Entamoeba histolytica in Japan
• Diagnosis of Amebiasis in Bangladesh

  back

Diseases of the pleura

• The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion
• use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural resulting from heart failure
• Transthoracic ultrasound for the pulmonologist
• Recent advances in the treatment of air leaks
• Pleural effusions in systemic amyloidosis
• Lymphocytes in pleural disease
• Alternative widely available, inexpensive agents for pleurodesis

  back

Liver and biliary tract disorders

• Update on viral hepatitis in 2004
• Sclerosing cholangitis
• Portal hypertension
• Pediatric hepatobiliary disease
• Liver transplantation
• Inherited metabolic liver disease
• Hepatocellular carcinoma
• Hepatobiliary pathology
• Drug-induced liver disease 2004
• Cholestasis and cholestatic syndromes
• Cholangiocyte biology
• Autoimmune liver disease
• Alcohol and the liver
• Liver and biliary tract disorders

  back

Allergic rhinitis

• Quality of life scales in allergic rhinitis
• Mediators of inflammation in the early and the late phase of allergic rhinitis
• Control of nasal obstruction in perennial allergic rhinitis
• An update on the asthma-rhinitis link
• Leukotriene receptor antagonists for allergic rhinitis
• Allergic Rhinitis And Asthma
• The Role Of Leukotriene Inhibitors In Allergic Rhinitis And Paranasal Sinusitis
• Treatment Of Allergic Rhinitis During Pregnancy
• Virus-Provoked Rhinitis And Asthma In Allergic Patients
• Rhinitis And Asthmathe Relationship Between Asthma And Allergic Rhinitis
• The Bone Marrow And Airway Inflammation-Evidence For Allergy As-Systemic Disease
• The Allergic Rhinitis-Asthma Connection
• Rhinitis And Asthmarole Of Leukotriene Receptor Antagonists In The Management Of Allergic Rhinitis And Comorbid Asthma
• Prevention Of Relapsing Rhino-Sinusal Polyposis
• Prevention Of Allergy And Asthma
• Nose And Lung Cross-Talk In Allergic Airways Disease
• Natural History Of Allergic Rhinitis
• Functional Relationships Between Allergic Rhinitis And Asthma
• Allergic Rhinitis-Current And Future Treatments
• Allergic Rhinitis And Its Impact On Asthma
• Allergic Rhinitis And Allergic Conjunctivitis
• Allergic rhinitis

  back

Inflammatory bowel disease

• Update in inflammatory bowel disease pathogenesis
• Therapy of ulcerative colitis
• The CD40-CD40L costimulatory pathway in inflammatory bowel disease
• Pregnancy and inflammatory bowel disease
• Pouchitis
• Pediatric inflammatory bowel disease
• New developments in experimental models of inflammatory bowel disease
• Medical therapy of Crohn disease
• Maintaining Remissions Across the Lifespan
• Long-Term Treatment of Crohn's Disease
• Lifelong Management of Mild to Moderate Crohn's Disease
• Biomarkers in inflammatory bowel disease
• Inflammatory bowel disease

  back

Genetics of disease

• Why genetic investigation of psychiatric disorders is so difficult
• Society and ethics – the genetics of disease
• Redundancy, insult-specific sensors and threshold
• Molecular genetics of Crohn’s disease
• Localization and identification of human quantitative trait loci
• Isolates and their potential use in complex gene mapping efforts
• Investigating gene function using mouse models
• Good copy, bad copy-choosing animal models for HLA-linked diseases
• Genetic dissection of diseases-design and methods
• genetic diseases associated with transcriptional derepression
• genetic architecture of quantitative traits
• designs used for tests of gene–environment interaction
• cv-Pathophysiology and biochemistry of cardiovascular disease
• Advances in chromatin remodeling and human disease
• Genetics of disease

  back

Reflux disease

• review of symptomatic outcomes used in oesophagitis drug therapy
• Quality of life assessment in gastro-oesophageal reflux disease
• Patient assessment of treatment satisfaction
• New approaches to enhance the accuracy of the diagnosis of reflux disease
• Diagnostic utility of reflux disease symptoms
• blueprint for symptom scales and responses
• Assessment of reflux symptom severity
• Reflux disease

  back

Inflammatory arthritis

• The TNF-a transgenic mouse model of inflammatory arthritis
• The SCID mouse model-novel therapeutic targets
• The KRN mouse model of inflammatory arthritis
• pathol-Immunopathogenesis of Collagen Arthritis
• Heat shock protein 60 and adjuvant arthritis
• Development of humanized mice as a model of inflammatory arthritis
• The Mast Cell in Inflammatory Arthritis
• Exploring The Reciprocal Relationship Between Immunity And Inflammation In Chronic Inflammatory Arthritis
• Inflammatory Arthritis In The Elderly
• The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover
• Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation
• Endostatin Gene Transfer Inhibits Joint Angiogenesis and Pannus Formation in Inflammatory Arthritis

  back

Peritoneal dialysis

• The natural course of peritoneal membrane biology during peritoneal dialysis
• Peritoneal dialysis solution biocompatibility
• Patient and technique survival on peritoneal dialysis in the United States
• Metabolic acidosis in maintenance dialysis patients
• In vitro biocompatibility performance of Physioneal
• Clinical indices of in vivo biocompatibility
• Buffer transport in peritoneal dialysis
• bicarbonate-buffered peritoneal dialysis solutions
• Acid-base profile in patients on PD
• peritoneal dialysis
• A solutions portfolio approach in peritoneal dialysis
• Clinical experience with two physiologic bicarbonate-lactate peritoneal dialysis solutions
• biocompatibility performance of a 25 mmol-L bicarbonate-10 mmol-L lactate-buffered peritoneal dialysis fluid
• Artificial Organs-Peritonitis In Peritoneal Dialysis
• Artificial Organs-Peritoneal Dialysis And Infection By Hepatitis-And-Virus
• Artificial Organs-Is There-Survival Advantage In Asian Peritoneal Dialysis Patients
• Spurious hyperglycaemia and icodextrin in peritoneal dialysis fluid
• Chronic Disease-Relationship Of Bioelectrical Impedance Parameters To Nutrition And Survival In Peritoneal Dialysis Patients
• Haemodialysis-Biocompatibility And Continuous Flow Peritoneal Dialysis
• Icodextrin--Review Of Its Use In Peritoneal Dialysis
• Prevention And Treatment Of Renal Disease-Peritoneal dialysis
• Microbiology and therapy of peritonitis in continuous peritoneal dialysis

  back

Inflammatory Bowel Diseases

• Enteric infection in relapse of inflammatory bowel disease importance of microbiological examination of stool
• Update in inflammatory bowel disease pathogenesis
• Therapy of ulcerative colitis
• The CD40-CD40L costimulatory pathway in inflammatory bowel disease
• Pregnancy and inflammatory bowel disease
• Pouchitis
• Pediatric inflammatory bowel disease
• New developments in experimental models of inflammatory bowel disease
• Medical therapy of Crohn disease
• Maintaining Remissions Across the Lifespan
• Long-Term Treatment of Crohn's Disease
• Lifelong Management of Mild to Moderate Crohn's Disease
• Biomarkers in inflammatory bowel disease
• Inflammatory bowel disease
• Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease
• Protein C pathways-endothelial protein C receptor and thrombomodulin in inflammatory bowel disease
• the risks and benefits of infliximab in the treatment
• experimental models of inflammatory bowel disease
• Cadherins-an integral role in inflammatory bowel disease
• Dysbiosis in inflammatory bowel disease
• New Developments In The Treatment Of Inflammatory Bowel Disease
• Probiotics And Inflammatory Bowel Disease
• Gene Transfer Approaches For The Treatment Of Inflammatory Bowel Disease
• Inflammatory Bowel Disease-The Genetics Of Inflammatory Bowel Disease
• Surveillance Colonoscopy For Colitic Cancer In Inflammatory Bowel Disease
• Surgery For Inflammatory Bowel Diseases
• Standard Treatment Of Ulcerative Colitis
• Standard Therapy Of Crohn's Disease
• Rationale For Probiotic And Antibiotic Treatment Strategies In Inflammatory Bowel Diseases
• Osteoporosis And Other Extraintestinal Symptoms And Complications Of Inflammatory Bowel Diseases
• New Diagnostic Avenues In Inflammatory Bowel Diseases
• Leukocytapheresis As An Adjunct To Conventional Medication For Inflammatory Bowel Disease
• Genetics Of Inflammatory Bowel Diseases-Past, Present, And Future
• Environmental Influences On Inflammatory Bowel Disease Manifestations
• Biological Therapy In Ibd
• Inflammatory Bowel Diseases
• Evaluation Of New Therapies For Inflammatory Bowel Disease
• Vascular Contribution In The Pathogenesis Of Inflammatory Bowel Disease
• The Immunological And Genetic Basis Of Inflammatory Bowel Disease
• Intestinal Tissue Kallikrein¨Ckallistatin Profile In Inflammatory Bowel Disease
• Gene transfer approaches for the treatment of inflammatory bowel disease
• Oxidative stress as a pathogenic factor in inflammatory bowel disease
• Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
• Delayed Puberty Associated with Inflammatory Bowel Disease
• Nutrition and adult inflammatory bowel disease
• Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases
• Inflammatory Bowel Disease and Spondylarthropathy
• New developments in the treatment of inflammatory bowel disease
• Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells-Implications for inflammatory bowel diseases
• Monitoring for drug side-effects in inflammatory bowel disease
• New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder
• Update on paediatric inflammatory bowel disease
• Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases
• disease models of inflammatory bowel disease
• New evidence for a viral pathogenic mechanism for new variant inflammatory bowel disease and development disorder
• Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease
• The efficacy of azathioprine for the treatment of inflammatory bowel disease
• treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
• The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
• Intestinal luminal pH in inflammatory bowel disease
• Inflammatory Bowel Disease-Inflammatory Bowel Disease(2)
• Inflammatory Bowel Disease-Inflammatory Bowel Disease
• Dysregulation of Intestinal Mucosal Immunity-Implications in Inflammatory Bowel Disease
• Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease
• the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment
• The genetics of inflammatory bowel disease
• Potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease
• Iron and inflammatory bowel disease
• 5-amino-salicylate in the management of inflammatory bowel disease
• the Pathogenesis of Inflammatory Bowel Disease
• EVOLVING TREATMENT STRATEGIES FOR INFLAMMATORY BOWEL DISEASE
• BOWEL-EVOLVING TREATMENT STRATEGIES FOR INFLAMMATORY BOWEL DISEASE
• future med-Prospects for Research in Inflammatory Bowel Disease
• INFLAMMATORY BOWEL DISEASE
• New cytokine treatment for inflammatory bowel disease
• Fibrogenesis IV- Fibrosis and inflammatory bowel disease

  back

Glomerulonephritis

• renal dis-glomerulonephritis-
• Cell cycle control in glomerular disease
• Chemokines- therapeutic targets for autoimmune and inflammatory renal disease
• Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease
• New insights into mechanisms of fibrosis in immune renal injury
• New insights into the pathogenesis of IgA nephropathy-Pathogenesis of IgA nephropathy
• Role of complement and complement regulatory proteins in glomerulonephritis
• Role of nephrin in proteinuric renal diseases
• T cells in glomerulonephritis
• The role of antibodies and B cells in the pathogenesis of lupus nephritis

  back

Phenylketonuria

• A role for overdominant selection in phenylketonuria
• bi-mi-db-PAHdb 2003- What a locus-specific knowledgebase can do
• Comparative multiplex dosage analysis detects whole exon deletions at the phenylalanine hydroxylase locus
• Focus on the Molecular Genetics of Phenylketonuria
• Genetic diversity within the R408W phenylketonuria mutation lineages
• How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters
• Mutations in the AUH gene cause 3-methylglutaconic aciduria type I
• Genotype-phenotype correlations based on expression analysis
• Phenylketonuria mutations in Europe

  back

Asthma – Managing a Variable Disease

• Immunoglobulin E Therapy for Asthma
• Cornerstone of Asthma Therapy
• Innervation of Equine Airways
• Introduction- Asthma- Managing a Variable Disease
• Living with a Variable Disease
• Managing a Variable Disease
• The Long and Short of 2-agonists
• Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment
• Mediators of Asthma- Nitric oxide

  back

Cough- Pharmacology and Therapy

• Animal Models for Cough
• Antitussive Effect of Nociceptin-Orphanin FQ in Experimental Cough Models
• Assessment and Measurement of Cough
• Assessment of Pharyngeal Sensitivity to Mechanical Stimuli Using Psychophysical and Electrophysiological Techniques
• Central Nervous Mechanisms of Cough
• Central Nervous Pharmacology of Cough
• Central Pathways for Cough in Man
• Chronic Cough and the Cough Reflex in Common Lung Diseases
• Clinical Needs for Cough Therapy
• Cough Provocation Tests
• Diagnosis and Treatment of Chronic Cough due to Gastro-esophageal Reflux Disease and Postnasal Drip Syndrome
• Editorial
• Epidemiology of Cough
• Functional Organization of the Central Cough Generation Mechanism
• Herbal Antitussives
• Hypersensitivity of Bronchopulmonary C-Fibers Induced by Airway Mucosal Inflammation
• Interactions between Vagal Afferent Nerve Subtypes Mediating Cough
• Mucociliary Transport and Cough in Humans
• Opioid Receptor Antagonists as a New Concept for Central Acting Antitussive Drugs
• Paediatric Problems of Cough
• Peripheral Pharmacology of Cough
• Physiology and Plasticity of Putative Cough Fibres
• Quality of Life in Coughers
• Relationship between Cough, Cough Receptor Sensitivity and Asthma in Children
• The Powerful Placebo in Cough Studies
• Therapy for Cough- Active Agents
• Voluntary Control of Cough
• Water Aerosols and Cough

  back

肾脏疾病的预防和治疗

• A basis for accelerated progression of diabetic nephropathy
• A stereological study of glomerular number and volume
• ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis
• Burden of end-stage renal disease
• Clinical renoprotection trials involving angiotensin II-receptor antagonists and ACEI
• End-stage renal disease and acute glomerulonephritis
• End-stage renal disease
• HemodialysisHemodialysis- Management problems in developing countries
• genetics-Nuclear genetic control of mitochondrial DNA segregation
• HIV-associated nephropathy
• Hypertensive risk factors in kidney disease
• Identification of persons at high risk for kidney disease via targeted screening
• Insulin resistance
• Intrauterine determinants of diabetic kidney disease
• Nephrology in China
• Paradigms of public-private partnerships in end-stage renal disease care
• Peritoneal dialysis
• Preventing renal disease
• Prevention of chronic renal failure
• genetics-OF EPONYMS, ACRONYMS AND ... ORTHONYMS
• Reduction in natural death and renal failure from a systematic screening and treatment program
• Renal transplantation in developing countries
• Taking a public health approach to the prevention of end-stage renal disease

  back

Allergic rhinitis & Asthma

• imm-Allergic rhinitis and asthma- epidemiological evidence for the link
• Allergic rhinitis and asthma-Functional relationships between allergic rhinitis and asthma
• Allergic rhinitis and asthma-Natural history of allergic rhinitis
• Allergic rhinitis and asthma-Nose and lung cross-talk in allergic airways disease
• Allergic rhinitis and asthma-The allergic rhinitis-asthma connection
• Allergic rhinitis and asthma-The allergic rhinitis-asthma connection-
• Allergic rhinitis and asthma-The bone marrow and airway inflammation
• Allergic rhinitis and asthma-Virus-provoked rhinitis and asthma in allergic patients

  back

Haematopoietic Disease

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Atypical Cellular Disorders
• Central Nervous System Lymphoma
• Chronic Lymphocytic Leukemia
• Chronic Myelogenous Leukemia
• Coagulation- Consultative Hemostasis
• Color Figures
• Enhancing Physician-Patient Communication
• Glossary of Molecular Biology Terminology
• Hematology Grants Workshop
• Hemophilia and Related Bleeding Disorders
• Hypercoagulability- Too Many Tests, Too Much Conflicting Data
• Lymphatics Make the Break
• Lymphoma of the Skin
• Malaria and the Red Cell
• Marrow Failure
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-Myeloablative Transplantation
• Novel Therapeutic Approaches in Sickle Cell Disease
• PATHOPHYSIOLOGICAL-BASED APPROACHES TO TREATMENT OF SICKLE CELL DISEASE
• Platelets- Thrombotic Thrombocytopenic Purpura
• Red Cell Antigens as Functional Molecules and Obstacles to Transfusion
• Regulation of Blood and Lymphatic Vascular Separation by Signaling Proteins SLP-76 and Syk
• PATHOGENESIS AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANT
• Stem Cell Transplantation- Supportive Care and Long-Term Complications
• Stem Cells- Hype and Reality
• Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma
  back

Chronic Obstructive Pulmonary Disease

• Chronic obstructive pulmonary disease - Introduction
• Experimental animal models of pulmonary emphysema
• Imaging the lungs in patients
• Systemic effects of COPD
• Susceptibility factors for COPD the genotype
• Pathology and biochemistry of emphysema
• Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease
  back

Immune Thrombocytopenias

• IMMUNE THROMBOCYTOPENIAS
• Acute immune (idiopathic) thrombocytopenic purpura in childhood
• Alloimmune thrombocytopenia of the fetus and the newborn
• Childhood chronic immune thrombocytopenic purpura
• Childhood immune thrombocytopenic purpura
• Classical management of refractory adult immune (idiopathic) thrombocytopenic purpura
• Clinical management of adult ITP prior to splenectomy
• Controversies in the treatment of pediatric immune thrombocytopenias
• DRUG-INDUCED AND DRUG-DEPENDENT IMMUNE THROMBOCYTOPENIAS
• Hematologic complications of primary immune deficiencies
• Heparin-induced thrombocytopenia
• HIV-related thrombocytopenia
• Humanized mouse models of FcR clearance in immune platelet disorders
• Idiopathic thrombocytopenic purpura complicating pregnancy
• Immune pathophysiology of autoimmune thrombocytopenic purpura
• Initial management of adults with idiopathic (immune) thrombocytopenic purpura
• MANAGEMENT OF ADULT IMMUNE THROMBOCYTOPENIA
• MANAGEMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
• NEW ASPECTS IN THE PATHOGENESIS AND TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA
• Novel approaches to refractory immune thrombocytopenic purpura
• Pathophysiology and thrombokinetics in autoimmune thrombocytopenia
• Pathophysiology of immune thrombocytopenic purpura
• Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura
• Pharmacoeconomics of therapy for ITP
• PLATELET GLYCOPROTEIN GENE POLYMORPHISMS AND RISK OF THROMBOSIS
• REVISITATION OF THE CLINICAL INDICATIONS FOR THE TRANSFUSION OF PLATELET CONCENTRATES
• Role of splenectomy in immune (idiopathic) thrombocytopenic purpura
• The potential role of thrombopoietin in idiopathic thrombocytopenic purpura
• Immune Thrombocytopenic Purpura
back

Malaria

• economic and social burden of malaria
• GlaxoSmithKline & malaria
• Malaria in 2002
• Medical need, scientific opportunity and the drive for antimalarial drugs
• Medicines for Malaria Venture
• pathogenic basis of malaria
• Plasmodium, human and Anopheles genomics and malaria
• Progress and challenges for malaria vaccines
• Satellite imagery in the study and forecast of malaria
• malaria
back

 

Mitochondrial disease

• potential roles in embryogenesis and nucleocytoplasmic transfer
• A nuclear modifier for a mitochondrial DNA disorder
• Homoplasmic Mitochondrial DNA Diseases as the Paradigm to Understand the Tissue Specificity
• Beyond the Magic Circle
• Clinical spectrum and diagnosis of mitochondrial disorders
• Cytochrome c oxidase deficiency
• disease models for mitochondrial disease
• Diseases caused by nuclear genes affecting mtDNA stability
• Epidemiology and treatment of mitochondrial disorders
• Mitochondria and degenerative disorders
• Mitochondria, oxygen free radicals, and apoptosis
• Mitochondrial DNA mutations in human disease
• Respiratory chain complex I deficiency
• The Pathophysiology of Mitochondrial Biogenesis
• Mitochondrial disorders-genetics, counseling, prenatal diagnosis and reproductive options
• Making mitochondrial mutants
• A critical appraisal of the mitochondrial coenzyme Q pool
• Mutation analysis in mitochondrial fatty acid oxidation defects
back

pediatric epilepsy

• Cognitive outcomes and predictive factors in epilepsy
• Depression and epilepsy
• Epilepsy surgery in children
• Integrating advances in pediatric epilepsy treatment options into clinical practice
• Integrating clinical trial data into clinical practice
• New dosages and formulations of AEDs for use in pediatric epilepsy
• Optimizing epilepsy management
• Optimizing health outcomes in active epilepsy
• Staged approach to epilepsy management
• The ketogenic diet
• Current status and future directions in the pharmacotherapy of epilepsy
• Mossy cells in epilepsy
• Current status and future directions in the pharmacotherapy of epilepsy
• Mossy cells in epilepsy
back

Headeche

• The role of concomitant headache types and non-headache
• Sinus headache or migraine
• Self-awareness of migraine
• Migraine and tension-type headache
• Diagnostic lessons from the Spectrum Study
• Diagnostic challenges in headache
• From CSD to headache-A long and winding roda
• Preventive Medicine-A Message from Preventive Medicine and Your Physician-Headaches
• Thunderclap headache

back

update of medicine

• Drug therapy for portal hypertension
• Update in Addiction Medicine
• Update in Allergy and Immunology
• Update in Cardiology
• Update in Critical Care Medicine
• Update in Critical Care Medicine-2
• Update in Gastroenterology
• Update in General Internal Medicine
• Update in Geriatrics
• Update in Hepatology
• Update in Hepatology-2
• Update in Hospital Medicine
• Update in Hospital Medicine-2
• Update in Immunology
• Update in Infectious Diseases
• Update in Oncology
• Update in Pulmonary Disease
• Update in Rheumatology
• Update in Women's Health
• Update on chronic viral hepatitis
• Update on Hypercoagulable Disorders
• Update on intravenous tissue plasminogen activator for acute stroke
• Atherosclerosis as an autoimmune disease
• Gene Therapy for Lung Disease-Hype or Hope
• Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction
• Papillomavirus research update
• Pathogenesis of urinary tract infections-an update
• The Role of the Implantable Cardioverter-Defibrillator for Prevention of Sudden Cardiac Death
• Uncomplicated Acute Bronchitis
• Vascular Adrenoceptors-An Update

back

Hepatitis

• Hepatitis B E antigen–negative chronic hepatitis B
• Hepatitis B immune globulin to prevent hepatitis B virus in liver transplantation
• Hepatitis B immunization in postpartum women
• Hepatitis B-Management of Hepatitis B
• Hepatitis C viral RNA-challenges and promises
• Hepatitis C virus cell culture replication systems-use for the development of antiviral therapies
• Hepatitis C Virus Resistance to Antiviral Therapy
• Human immunodeficiency virus-hepatitis C coinfection
• Acute Flares in Chronic Hepatitis B
• Acute hepatitis C
• Autoimmune Hepatitis
• Chronic Hepatitis B Virus Infection-Treatment Strategies for the Next Millennium
• MHC and the viral hepatitides
• Molecular Anatomy and Pathophysiologic Implications of Drug Resistance in Hepatitis B Virus Infection
• Mother-to-infant transmission of hepatitis C virus
• Natural history of chronic hepatitis C
• Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
• Treatment of chronic hepatitis
• vaccine-
• Advances in the Molecular Diagnosis of Hepatitis C and Their Clinical Implications
• Advances in the molecular diagnosis of hepatitis C and their clinical implications
• Current concepts inthe diagnosis, pathogenesis, and treatment of autoimmune hepatitis
• Combination therapy for hepatitis B.
• Autoimmune hepatitis and its variant syndromes
• Hepatitis A, Hepatitis B, and Combination Hepatitis Vaccines for Immunoprophylaxis

back

Endometriosis

• A Novel Therapeutic Concept in Endometriosis
• A Regulatory System Altered in Endometriosis
• Angiogenic Factors in Endometriosis
• Autoantibody Responses to Carbohydrate Epitopes in Endometriosis
• Circulating Ovarian Steroids and Endometrial Matrix Metalloproteinases
• Control of Growth and Differentiation of the Endometrium
• Conventional Medical Therapies for Endometriosis
• Endometriosis and Infertility
• Environmental Contaminants and Dietary Factors in Endometriosis
• Environmental Toxicants in the Pathophysiology of Endometriosis
• Epidemiology of Endometriosis
• Estrogen Production and Metabolism in Endometriosis
• Experimental Endometriosis
• Future Research Directions and Recommendations
• Genetic Epidemiology of Spontaneous Endometriosis in the Rhesus Monkey
• Heritability and Molecular Genetic Studies of Endometriosis
• Implantation Defects in Infertile Women with Endometriosis
• Local Cytokines in Endometrial Tissue
• Macrophages, Oxidation, and Endometriosis
• Mechanisms of Action of Estrogen and Progesterone
• Modified Baboon Model for Endometriosis
• olecular Basis for Implantation Failure in Endometriosis
• Overviews-What Is Endometriosis
• Paracrine Mediators of Endometrial Matrix Metalloproteinase Expression
• Paracrine Regulation of Matrix Metalloproteinase Expression in Endometriosis
• Premenstrual and Menstrual Changes in the Macaque and Human Endometrium
• Regulation and Modulation of Abnormal Immune Responses in Endometriosis
• Research Aspects of Endometriosis Surgery
• Role of Endometriosis in Cancer and Tumor Development
• Treatment of Endometriosis
• Treatment of EndometriosisTreatment of Endometriosis
• Using Rats as a Research Model for the Study of Endometriosis

back

Screening for Disease

• Case finding and screening strategies for thyroid dysfunction
• Economic evaluations of screening programs-a review of methods and results
• Foreword to Screening for Disease
• Introduction to Screening for Disease,
• Neonatal biochemical screening for disease
• Objective evaluation of data in screening for disease
• Pharmacogenetic screening and therapeutic drugs
• Screening for cardiovascular disease with cholesterol
• Screening for diabetes
• Screening for hemochromatosis
• Screening for prostate cancer with prostate-specific antigen
• Screening for the early detection of disease, the need for evidence
• Some ethical and design challenges of screening programs and screening tests
• Stool screening for colorectal cancer
• Urine drug screening in the medical setting

back

心动过速（01-08）

• Internal Cardioversion of Atrial Fibrillation-New Information
• Ablation for Atrial Fibrillation- An Update
• Atrial Fibrillation- Experimental and Theoretical Developments
• Atrial Fibrillation Update- Overview and Highlights of New Information
• Atrial Update
• Atrioventricular Conduction Disturbances
• Computer Modeling of Atrial Fibrillation
• Cardioversion of Atrial Fibrillation
• Catheter Maze-Ablation for Preventing Atrial Fibrillation- Where Do We Stand
• Circulatory Assist Devices for the Management of Intractable Ventricular Tachyarrhythmias
• Immediate Management of Atrial Fibrillation- State of the Art
• Inappropriate Sinus An Update
• Intractable Ventricular Tachyarrhythmias
• Invasive Electrophysiologic Techniques in the Management of Intractable Ventricular Arrhythmias
• Long-term Management of Atrial Fibrillation- State of the Art
• Mortality in Atrial Fibrillation
• New Options for Pharmacological Conversion of Atrial Fibrillation
• New Results from Trials in Atrial Fibrillation
• Noninvasive Methods in Atrial Fibrillation
• Operative Management of Intractable Ventricular Tachyarrhythmias
• Pathophysiology of Atrial Fibrillation
• Polymorphic Ventricular Tachycardia
• Prevention of Thromboembolism in the Unstable or Complex Patient with Atrial Fibrillation
• Risk Stratification for Thromboprophylaxis in Atrial Fibrillation
• Sinus Node Dysfunction
• Sustained Monomorphic Ventricular Tachycardia
• Related Cardiomyopathy in Patients with Atrial Fibrillation
• Update on Antithrombotic Therapy in Atrial Fibrillation
• Ventricular Fibrillation- Experimental and Theoretical Developments
• Ventricular Fibrillation- Immediate Evaluation and Management efibrillation
• What's the Best Drug for Maintaining Sinus Rhythm

back

盆腔痛（01-08）

• Diagnosis and treatment issues of chronic pelvic pain
• Gastroenterological causes of pelvic pain
• Neurogenic inflammation and chronic pelvic pain
• Physical therapy management of pelvi-perineal and perianal pain syndromes
• The pelvic pain centre
• Review on chronic pelvic pain from a urological point of view

back